PATENT CLAIM ANALYSIS

Application Number: 15742422
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "129000"]

Abstract:
Compounds are provided according to Formula (I) and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R 1 , R 2 , R 3 , R 4 , R 5 , and R 8  are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

Claim (Index 10):
The compound of  claim 8 , wherein R 1  is hydrogen, methyl (e.g., \u2014CH 3 , \u2014CF 3  or \u2014CH 2 OCH 3 ), ethyl, or isopropyl.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15552201', '15660114', '15312614', '13993198', '15314599']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7805441599669543
- 35 USC 102 Novelty (BERT): 0.5533489758855705
- Combined Prediction Score: 0.7578246415588159
- Mean Citation Score: 344.124902
- Max Citation Score: 358.68613
- Similarity Product: 247.26154831315816

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test